These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2354878)
1. Synthesis of peptide-immunogens corresponding to amino acid sequences from human histocompatibility class II membrane glycoproteins. Chillemi F; Cappelletti S; Francescato P; Chersi A Int J Pept Protein Res; 1990 Mar; 35(3):271-80. PubMed ID: 2354878 [TBL] [Abstract][Full Text] [Related]
2. Recognition of HLA class II molecules by antipeptide antibodies elicited by synthetic peptides selected from regions of HLA-DP antigens. Chersi A; Houghten RA; Morganti MC; Muratti E Z Naturforsch C J Biosci; 1987; 42(11-12):1313-8. PubMed ID: 2966503 [TBL] [Abstract][Full Text] [Related]
3. Immunologic and functional characterization of anti-HLA-DR rabbit antibodies induced by synthetic peptides. Chersi A; Schulz G; Houghten RA Mol Immunol; 1984 Oct; 21(10):847-52. PubMed ID: 6334232 [TBL] [Abstract][Full Text] [Related]
4. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Tam JP Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5409-13. PubMed ID: 3399498 [TBL] [Abstract][Full Text] [Related]
5. Specificity of anti-MHC class II antibody binding to synthetic peptides. Chersi A; Romano TF; Ruocco E Z Naturforsch C J Biosci; 1989; 44(9-10):886-9. PubMed ID: 2590345 [TBL] [Abstract][Full Text] [Related]
6. Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1. Krasko AG; Moshnikova AB; Kozhich AT; Tchikin LD; Ivanov VT; Vladyko AS; Lukashevich IS Arch Virol; 1990; 115(1-2):133-7. PubMed ID: 1701079 [TBL] [Abstract][Full Text] [Related]
7. Generation of rabbit antipeptide antibodies to HLA-class II antigens by the use of synthetic peptides. Chersi A; Morganti MC; Chillemi F; Houghten R; Cenciarelli C Clin Exp Immunol; 1988 Jul; 73(1):76-81. PubMed ID: 3168331 [TBL] [Abstract][Full Text] [Related]
8. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein. Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311 [TBL] [Abstract][Full Text] [Related]
9. Production of antisera using peptide conjugates. Adrian TE Methods Mol Biol; 1997; 73():239-49. PubMed ID: 9031212 [No Abstract] [Full Text] [Related]
10. Characterization of antisera directed against follistatin/activin-binding protein peptides. Saito S; Sugino K; Yamanouchi K; Kogawa K; Titani K; Shiota K; Takahashi M; Sugino H Endocrinol Jpn; 1991 Aug; 38(4):377-82. PubMed ID: 1802678 [TBL] [Abstract][Full Text] [Related]
11. A sensitive method to detect defined peptide among those eluted from murine MHC class II molecules. Brumeanu TD; Kohanski R; Bona CA; Zaghouani H J Immunol Methods; 1993 Mar; 160(1):65-71. PubMed ID: 8450239 [TBL] [Abstract][Full Text] [Related]
12. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide. Christodoulides M; McGuinness BT; Heckels JE J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983 [TBL] [Abstract][Full Text] [Related]
13. A structural analysis of the carbohydrate side chains on class I and class II histocompatibility antigens of the swine facilitated by heteroantisera specific for the denatured polypeptides. Alting-Mees M; Barber BH Mol Immunol; 1986 Aug; 23(8):847-61. PubMed ID: 3796628 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response. Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; van Eden W; de Baets MH Eur J Immunol; 1996 Dec; 26(12):2866-75. PubMed ID: 8977279 [TBL] [Abstract][Full Text] [Related]
16. Multiple antigen peptides (MAPs) as candidate vaccines against malaria. Pessi A; Bianchi E; Chiappinelli L; Bonelli F; Tougne C; Lambert PH; Del Giudice G Parassitologia; 1991 Apr; 33(1):79-84. PubMed ID: 1668679 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and application of peptide immunogens related to the sperm tail protein tpx-1, a member of the CRISP superfamily of proteins. Keah HH; O'Bryan MK; de Kretser DM; Hearn MT J Pept Res; 2001 Jan; 57(1):1-10. PubMed ID: 11168883 [TBL] [Abstract][Full Text] [Related]
18. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405 [TBL] [Abstract][Full Text] [Related]
19. Identification of linear HLA class II amino acid sequences recognized by rabbit antisera against native molecules. Chersi A; Morganti MC; Houghten R; Chillemi F; Muratti E Scand J Immunol; 1987 Dec; 26(6):723-9. PubMed ID: 2447636 [TBL] [Abstract][Full Text] [Related]
20. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Sette A; Buus S; Appella E; Smith JA; Chesnut R; Miles C; Colon SM; Grey HM Proc Natl Acad Sci U S A; 1989 May; 86(9):3296-300. PubMed ID: 2717617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]